Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Analysis of CLSA Data

University of Ottawa

$70,000.00

Retinal vessel traits as biomarkers for systemic small vessel disease: Are they valid surrogate outcomes?

FY 2025-26

Summary
We recently reported that characteristics of small blood vessels in the retina (e.g. width, curvature) were related to both the presence and 3-year onset of age-related macular degeneration (AMD). Clinicians have noted that the presence of one small vessel disease like AMD is often accompanied by others throughout the body such as dementia, stroke, kidney disease, peripheral vascular disease, and type 2 diabetes. This observation has led to the hypothesis that a single underlying condition affects all small vessels in the body and is worsened by age and vascular factors like high blood pressure, which can cause remodeling of the vessels (i.e. changes to vessel width and curvature). Thankfully, researchers have reported that modifiable factors like physical activity, weight loss, smoking cessation, and medication for high blood pressure and high cholesterol may improve the condition of the retinal vessels. Given the eye is easily accessible by camera, researchers have investigated whether the condition of the retinal vessels can act as a biomarker of the health of the other less accessible small vessels in the body. If true, retinal vessels could be used as a surrogate outcome for small vessel diseases and prevention and treatment trials could be shorter and cheaper. However, evidence to support the use of retinal vessels as a valid surrogate outcome is incomplete. Our work will provide evidence on whether retina vessel traits can be used as valid surrogate outcomes for small vessel diseases.
Program
Catalyst Grant: Analysis of CLSA Data
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
536563
Name
Freeman Ellen
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Clinical
Prcname2
Catalyst Grant: Analysis of CLSA Data
Projecttitle
Retinal vessel traits as biomarkers for systemic small vessel disease: Are they valid surrogate outcomes?
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Analysis of CLSA Data
Keyworddelim
Age-Related Macular Degeneration; Dementia; Epidemiology; Mediation; Polygenic Risk Scores; Retinal Vessels; Small Vessel Diseases; Stroke
Abstract
We recently reported that characteristics of small blood vessels in the retina (e.g. width, curvature) were related to both the presence and 3-year onset of age-related macular degeneration (AMD). Clinicians have noted that the presence of one small vessel disease like AMD is often accompanied by others throughout the body such as dementia, stroke, kidney disease, peripheral vascular disease, and type 2 diabetes. This observation has led to the hypothesis that a single underlying condition affects all small vessels in the body and is worsened by age and vascular factors like high blood pressure, which can cause remodeling of the vessels (i.e. changes to vessel width and curvature). Thankfully, researchers have reported that modifiable factors like physical activity, weight loss, smoking cessation, and medication for high blood pressure and high cholesterol may improve the condition of the retinal vessels. Given the eye is easily accessible by camera, researchers have investigated whether the condition of the retinal vessels can act as a biomarker of the health of the other less accessible small vessels in the body. If true, retinal vessels could be used as a surrogate outcome for small vessel diseases and prevention and treatment trials could be shorter and cheaper. However, evidence to support the use of retinal vessels as a valid surrogate outcome is incomplete. Our work will provide evidence on whether retina vessel traits can be used as valid surrogate outcomes for small vessel diseases.
Competitiondate
202510
Approvedterm2
1 yr 0 mth
Pinamesdelim
Freeman, Ellen; Roy-Gagnon, Marie-Hélène
Approvedterm
1 an 0 mois
Cihrcontribution2
INMD~ $70,000~ $0~
University of Ottawa - $70,000 Grant (2025-26) | Canada Spends